Currently KNOS is in an ascending bull flag.

Why KNOS has huge potential within the months to come:

Their air filtration technology fully removes harmful allergens, bacteria, viruses (including the flu) and even gases from your breathing space. This product far outperforms the outdated 1940’s technology of a HEPA filter, and eliminates the shortcomings of any other air

Kronos owns 12 patents in total, all focused on air filtration, and the removal of harmful bacteria, allergens and viruses from the breathing space.
Patents:
US 7,150,780 B2
US 6,937,455 B2
US 6,919,698 B2
US 6,727,657 B2
US 7,122,070 B1
US 6,963,479 B2
US 7,053,565 B2
US 6,664,741 B1
US 2010/0047115 A1
US 2009/0022340 A1
US 2010/0065510 A1
US 2010/0065510 A1

June 18th, 2020, Kronos signs deal to acquire US based leader in electronics manufacturing industry including its 85,000 square foot manufacturing facility. Kronos announced that it has signed a “Letter of Intent” with a privately held company to acquire a manufacturing facility for its consumer electronics products operations. The Company plans to manufacture a variety of electronic products, including medical ventilators and other vitally necessary medical equipment in addition to its flagship air purification products.

Having their own manufacturing facility would not only help them to scale production to address growing sales and product line expansion, but also to develop new products and bring those to market much faster under a more efficient and controllable cost structure.

June 29th, 2020 Kronos starts taking pre-orders for air purification products.
Beyond Technical AnalysisChart PatternscoronaCoronavirus (COVID-19)coronoviruscovid19stockOTCpennystockpennystocksTrend Analysis

إخلاء المسؤولية